Presentation is loading. Please wait.

Presentation is loading. Please wait.

Approach to the Ground-Glass Nodule

Published byArlene Gregory Modified over 6 years ago

Similar presentations

Presentation on theme: "Approach to the Ground-Glass Nodule"— Presentation transcript:

1 Approach to the Ground-Glass Nodule
Frank C. Detterbeck, MD, Robert J. Homer, MD, PhD  Clinics in Chest Medicine  Volume 32, Issue 4, Pages (December 2011) DOI: /j.ccm Copyright © 2011 Elsevier Inc. Terms and Conditions

2 Fig. 1 Suzuki classification of GGOs. Radiographic classification of lung nodules according to the ground-glass component by Suzuki and colleagues.2 (Data from Suzuki K, Kusumoto M, Watanabe S, et al. Radiologic classification of small adenocarcinoma of the lung: radiologic-pathologic correlation and its prognostic impact. Ann Thorac Surg 2006;81:413–9.) Clinics in Chest Medicine  , DOI: ( /j.ccm ) Copyright © 2011 Elsevier Inc. Terms and Conditions

3 Fig. 2 Findings at resection of a GGO. Distribution of diagnoses of resected lesions for (A) pure GGO and (B) semisolid GGO lesions. AAH, atypical adenomatous hyperplasia; Adeno, adenocarcinoma; AIS, adenocarcinoma in situ; F/U mo, follow-up period (in months); N pts, number of patients. (Part (A) Data from Refs.15,26,44,46,73–75; and (B) Data from Refs.12,15,26,46,59,60,74–77) Clinics in Chest Medicine  , DOI: ( /j.ccm ) Copyright © 2011 Elsevier Inc. Terms and Conditions

4 Fig. 3 Diagnosis according to size. Diagnosis according to size for (A) pure GGO and (B) semisolid GGO. AAH, atypical adenomatous hyperplasia; Adeno, adenocarcinoma; AIS, adenocarcinoma in situ; F/U mo, follow-up period (in months); N pts, number of patients; NSCLC, non–small cell lung carcinoma. (Part (A) Data from Refs.17,46,58,60,78; and (B) Data from Refs.46,59,75) Clinics in Chest Medicine  , DOI: ( /j.ccm ) Copyright © 2011 Elsevier Inc. Terms and Conditions

5 Fig. 4 Outcomes during observation. Outcomes of GGO lesions after a period of observation. BAC, bronchioloalveolar carcinoma; F/U mo, follow-up period (in months); N pts, number of patients. (Data from Refs.10,15–17,57,60,79) Clinics in Chest Medicine  , DOI: ( /j.ccm ) Copyright © 2011 Elsevier Inc. Terms and Conditions

6 Fig. 5 Diagnoses during observation. Diagnoses made during observation. AAH, atypical adenomatous hyperplasia; Adeno, adenocarcinoma; AIS, adenocarcinoma in situ; F/U mo, follow-up period (in months); N pts, number of patients. (Data from Refs.10,15–17,57,60,73,79) Clinics in Chest Medicine  , DOI: ( /j.ccm ) Copyright © 2011 Elsevier Inc. Terms and Conditions

Download ppt "Approach to the Ground-Glass Nodule"

Similar presentations

Pathologic N1 non-small cell lung cancer: Correlation between pattern of lymphatic spread and prognosis Alessandro Marra, MD, PhD, Ludger Hillejan, MD,

Pathologic N1 non-small cell lung cancer: Correlation between pattern of lymphatic spread and prognosis Alessandro Marra, MD, PhD, Ludger Hillejan, MD,
Multifocal adenocarcinoma in situ (AIS), formerly known as bronchioloalveolar cell carcinoma (BAC). (A, B) Two chest CT sections obtained approximately.

Multifocal adenocarcinoma in situ (AIS), formerly known as bronchioloalveolar cell carcinoma (BAC). (A, B) Two chest CT sections obtained approximately.
Carcinoma NOS is a Common Histologic Diagnosis and is Increasing in Proportion Among Non-small Cell Lung Cancer Histologies  Sai-Hong Ignatius Ou, MD,

Carcinoma NOS is a Common Histologic Diagnosis and is Increasing in Proportion Among Non-small Cell Lung Cancer Histologies  Sai-Hong Ignatius Ou, MD,
Which is the Better Prognostic Factor for Resected Non-small Cell Lung Cancer: The Number of Metastatic Lymph Nodes or the Currently Used Nodal Stage.

Which is the Better Prognostic Factor for Resected Non-small Cell Lung Cancer: The Number of Metastatic Lymph Nodes or the Currently Used Nodal Stage.
The eighth edition TNM stage classification for lung cancer: What does it mean on main street?  Frank C. Detterbeck, MD  The Journal of Thoracic and Cardiovascular.

The eighth edition TNM stage classification for lung cancer: What does it mean on main street?  Frank C. Detterbeck, MD  The Journal of Thoracic and Cardiovascular.
A Proposal for Definition of Minimally Invasive Adenocarcinoma of the Lung Regardless of Tumor Size  Shigeki Suzuki, MD, Hiroyuki Sakurai, MD, Kyohei.

A Proposal for Definition of Minimally Invasive Adenocarcinoma of the Lung Regardless of Tumor Size  Shigeki Suzuki, MD, Hiroyuki Sakurai, MD, Kyohei.
Now or Later: Evaluating the Importance of Chemotherapy Timing in Resectable Stage III (N2) Lung Cancer in the National Cancer Database  Daniel J. Boffa,

Now or Later: Evaluating the Importance of Chemotherapy Timing in Resectable Stage III (N2) Lung Cancer in the National Cancer Database  Daniel J. Boffa,
Pannus Attack: Septic Thrombophlebitis

Pannus Attack: Septic Thrombophlebitis
The Lung Reporting and Data System (LU-RADS): A Proposal for Computed Tomography Screening  Daria Manos, MD, Jean M. Seely, MD, Jana Taylor, MD, Joy Borgaonkar,

The Lung Reporting and Data System (LU-RADS): A Proposal for Computed Tomography Screening  Daria Manos, MD, Jean M. Seely, MD, Jana Taylor, MD, Joy Borgaonkar,
A Novel Classification of MUC1 Expression Is Correlated with Tumor Differentiation and Postoperative Prognosis in Non–Small Cell Lung Cancer  Shinjiro.

A Novel Classification of MUC1 Expression Is Correlated with Tumor Differentiation and Postoperative Prognosis in Non–Small Cell Lung Cancer  Shinjiro.
Surgical–pathologic factors affect long-term outcomes in stage IB (pT2 N0 M0) non– small cell lung cancer: A heterogeneous disease  Chung-Ping Hsu, MD,

Surgical–pathologic factors affect long-term outcomes in stage IB (pT2 N0 M0) non– small cell lung cancer: A heterogeneous disease  Chung-Ping Hsu, MD,
Volume 142, Issue 6, Pages (December 2012)

Volume 142, Issue 6, Pages (December 2012)
Ground glass opacities: Imaging, pathology, and gene mutations

Ground glass opacities: Imaging, pathology, and gene mutations
Fate of Newly Detected Lesions During Postoperative Surveillance for Non-Small Cell Lung Cancer  Jae-Ik Lee, MD, PhD, Young-Jin Lee, RN, Kook-Yang Park,

Fate of Newly Detected Lesions During Postoperative Surveillance for Non-Small Cell Lung Cancer  Jae-Ik Lee, MD, PhD, Young-Jin Lee, RN, Kook-Yang Park,
Impact of tumor size on outcomes after anatomic lung resection for stage 1A non–small cell lung cancer based on the current staging system  Shamus R.

Impact of tumor size on outcomes after anatomic lung resection for stage 1A non–small cell lung cancer based on the current staging system  Shamus R.
Clinical Prognosis of Superior Versus Basal Segment Stage I Non-Small Cell Lung Cancer  Yoshinori Handa, MD, Yasuhiro Tsutani, MD, PhD, Norifumi Tsubokawa,

Clinical Prognosis of Superior Versus Basal Segment Stage I Non-Small Cell Lung Cancer  Yoshinori Handa, MD, Yasuhiro Tsutani, MD, PhD, Norifumi Tsubokawa,
Details and Difficulties Regarding the New Lung Cancer Staging System

Details and Difficulties Regarding the New Lung Cancer Staging System
Prognostic Impact of Margin Distance and Tumor Spread Through Air Spaces in Limited Resection for Primary Lung Cancer  Kyohei Masai, MD, Hiroyuki Sakurai,

Prognostic Impact of Margin Distance and Tumor Spread Through Air Spaces in Limited Resection for Primary Lung Cancer  Kyohei Masai, MD, Hiroyuki Sakurai,
Tetsuya Mitsudomi, MD, Hirohito Tada, MD  Journal of Thoracic Oncology 

Tetsuya Mitsudomi, MD, Hirohito Tada, MD  Journal of Thoracic Oncology 
Outcomes of unexpected pathologic N1 and N2 disease after video-assisted thoracic surgery lobectomy for clinical stage I non–small cell lung cancer  Hong.

Outcomes of unexpected pathologic N1 and N2 disease after video-assisted thoracic surgery lobectomy for clinical stage I non–small cell lung cancer  Hong.

Similar presentations

Ads by Google